1.Serum CA 125 Levels in Patients with Impaired Renal Function.
Jong Hyeok KIM ; Yong Man KIM ; Young Tak KIM ; Joo Hyun NAM ; Jung Eun MOK
Korean Journal of Gynecologic Oncology and Colposcopy 1996;7(3):182-188
Measurement of the serum CA 125 level as a tumor marker in patients with epithelial ovarian cancer has been widely used to monitor disease status and predict survival of patient. While a number of benign gynecologic as well as benign or malignant non-gynecologic conditions are associated with elevations of serum CA 125 levels, the established normal range describes a healthy population of women. Because the metabolism and clearance of CA 125 is not well understood and mild or moderate degrees of renal impairment frequently occurs in ovarian cancer patients during treatment or course of disease, it is valuable to investigate the effect of impaired renal function on serum level of CA 125. Eighty-nine women on hemodialysis who had no other definite cause to elevate serum CA 125 level were selected at random. The age of the patients ranged from 19 to 83 and renal disease was secondary in most cases to diabetes mellitus, hypertension or glomeru-lonephritis. The creatinine clearance was less than 10cc/min for all patients. (continue)
Creatinine
;
Diabetes Mellitus
;
Female
;
Humans
;
Hypertension
;
Metabolism
;
Ovarian Neoplasms
;
Reference Values
;
Renal Dialysis
2.Neuropsychological profiles and their correlation to motor symptoms in newly diagnosed Parkinsondisease patients with mild cognitive impairment
Eun Joo Chung ; Jae-Hyeok Lee ; Kyngha Seok ; Sang Jin Kim
Neurology Asia 2014;19(1):19-25
Background & Objectives: Frontal executive dysfunction, which is hypothesized to reflect dorsolateral
prefrontal function, predominates in Parkinson’s disease (PD). Visuospatial dysfunction and episodic
memory deficit, which are associated with the posterior cortical area, are critical symptoms of mild
cognitive impairment in PD (PD-MCI). The first aim of this study is to investigate whether dominant
cognitive deficits are caused by posterior cortical dysfunction in drug naïve, de novo PD-MCI patients.
The second aim is to analyze the relationship between parkinsonian motor symptoms and the cognitive
domain in these patients. Methods: Newly diagnosed PD patients who had not received treatment were
divided into two subgroups as follows: PD-MCI (n=39) and PD patients with normal cognition (PD-NC)
(n=39). Various neuropsychological tests were performed in all of the patients. The parkinsonian motor
subscores were divided into tremor, rigidity, axial impairment, bulbar dysfunction and bradykinesia
by the UPDRS motor scores. Results: Verbal episodic memory (immediate recall; p = 0.0001, delayed
recall; p = 0.0001, recognition; p = 0.003), visual episodic memory (immediate recall; p = 0.0001,
delayed recall; p = 0.002) and visuospatial function (p = 0.046) were lower in the PD-MCI group
than in the PD-NC group. In the analysis of the correlation of the motor components to the cognitive
tests, impairment in visual episodic memory correlated with axial symptoms (immediate recall; r =
-0.441, p = 0.021, delayed recall; r = -0.393, p = 0.042). The contrast program test correlated with
bradykinesia (r = -0.479, p = 0.013)
Conclusion: Episodic memory and visuospatial dysfunction, which reflect impairment of the posterior
cortical area, are critical cognitive deficits, and memory impairment is correlated with the axial symptoms
that are associated with non-dopaminergic pathways in newly diagnosed PD-MCI patients.
3.The Overxpression of p53 in gestational Trophoblastic Disease and Normal Human Placenta.
Sung Ook WHANG ; Jong Hyeok KIM ; Jooryung HUH ; Yong Man KIM ; Young Tak KIM ; Joo Hyun NAM ; Jung Eun MOK
Korean Journal of Gynecologic Oncology and Colposcopy 1997;8(3):300-314
Mutations in the tumor suppressor p53 gene are the most frequently observed genetic lesions in human cancers. It seems that wild type p53 does significant role on growth and differentiation of normal cells, Mutations and allelic loss of the p53 gene are thought to be a cause of tumor development and to be correlated with the prognostic factors in various human cancers such as breast, ovary and lung cancer. Mutant p53 proteins have a prolonged half-life and can be detected by immunohistochemistry. In case of GTD(gestational trophoblastic disease), although the mutation of p53 gene mutation was revealed to be very rare, the overexpression of p53 in immunohistochemical staining has been reported in wide range of discrepancy and its role or prognostic significance in GTD is uncertain. This study is performed to define the status of p53 overexpression in GTD and to evaluate the correlations between p53 overexpression and prognostic factors of GTD. THE RESULTS WERE AS FOLLOWS: 1. p53 overexpression was detected in none of normal placental tissue, in 58.3%(14/24) of hydatidiform mole, in 15%(6/8) of invasive mole, in 75%(3/4) of choriocarcinoma, and in 100%(1/1) of placental site trophoblastic tumor, and showed significant difference between normal placenta and GTD. We could not find any difference of the p53 overexpression between benign group(H-mole) of GTD and malignant one(invasive mole, choriocarcinoma, and placental site trophoblastic tumor) 2. In H-mole, low-risk group showed significantly higher prevalence of p53 overexpression than high-risk group did. In malignant group, there is no difference in the prevalence of p53 overexpression between early(FIGO stage I) and late(II- IV)stage-diseases, but the prevalence of p53 overexpression of low-risk group is slightly higher than that of high-risk group although we failed to find statistical significance. In conclusion, the high prevalence of p53 overexpression in GTD suggests that p53 may have a certain role in the pathogenesis of GTD or at least represent generalized DNA damage or genetic instability of GTD. And the higher prevalence of p53 overexpression in low-risk group suggests that accumulation of wild-type p53 may be related with favorable prognosis in GTD.
Breast
;
Choriocarcinoma
;
DNA Damage
;
Female
;
Genes, p53
;
Gestational Trophoblastic Disease*
;
Half-Life
;
Humans*
;
Hydatidiform Mole
;
Hydatidiform Mole, Invasive
;
Immunohistochemistry
;
Loss of Heterozygosity
;
Lung Neoplasms
;
Ovary
;
Placenta*
;
Pregnancy
;
Prevalence
;
Prognosis
;
Trophoblastic Tumor, Placental Site
;
Trophoblasts
4.Primary transitional cell carcinoma of the fallopian tube: A case report.
Jong Hyeok KIM ; Jooryung HUH ; Yong Man KIM ; Young Tak KIM ; Joo Hyun NAM ; Jung Eun MOK
Korean Journal of Gynecologic Oncology and Colposcopy 1997;8(1):82-88
No abstract available.
Carcinoma, Transitional Cell*
;
Fallopian Tubes*
;
Female
5.DNA Ploidy Heterogeneity in Primary an Metastatic Lesion of Epithelial Ovarian Cancer.
Jong Hyeok KIM ; Joo Hyun NAM ; Joo Ryung HUH ; Yong Man KIM ; Young Tak KIM ; Jung Eun MOK
Korean Journal of Obstetrics and Gynecology 1997;40(1):170-180
Tumor DNA content measured by flow cytometry may be a predictor in the prognosis of epithelial ovarian cancer, but the results have been inconsistent. It is recognized that these conflicting results are at least partly due to the variation of DNA content between the samples from the same patient(i.e., intratumoral DNA heterogeneity). The purposes of this retrospective study were to investigate the frequency and the nature of DNA heterogeneity in epithelial ovarian cancer and to evaluate the prognostic significance of DNA heterogenetiy itself. Thirty-two patients with stage II to IV epithelial ovarian cancer who were managed at Asan Medical Center between May 1993 and April 1996 were analysed. Measurements of the nuclear DNA content were performed on samples from primary and metastatic lesion using paraffin embedded archival tissues by Epics(Coulter Inc.) flow cytometry. In two cases, the metastatic tumor was minute and did not reveal a separable peak on repeated examination. DNA heterogeneity was defined as different ploidy pattern or difference of the DNA indices than 0.15 between primary and metastatic tumors. DNA heterogeneity was found in 11 cases(36.7%), and the number of cases with homogeneous diploid and that with homogeneous aneuploid tumor were 5(16.7%) and 14(46.7%) respectively. In evaluation of prognostic significance of DNA heterogeneity using correlation with serum CA 125 level after second course of chemotherapy and residual tumor size after cytoreductive surgery among these three groups, the patients with DNA heterogeneity were considered to show intermediate prognosis between those with homogeneous diploid and homogeneous aneuploid tumor. In conclusion, DNA heterogeneity in epithelial ovarian cancer is considerable in frequency and may have prognostic value.
Aneuploidy
;
Chungcheongnam-do
;
Diploidy
;
DNA*
;
Drug Therapy
;
Flow Cytometry
;
Humans
;
Neoplasm, Residual
;
Ovarian Neoplasms*
;
Paraffin
;
Ploidies*
;
Population Characteristics*
;
Prognosis
;
Retrospective Studies
6.Peer-assisted learning to train high-school students to perform basic life-support
Soo-Hyung CHOI ; Hoon-Dong LEE ; Woong-Chan KIM ; Eun-Sung KIM ; Hyeok-Je OH
World Journal of Emergency Medicine 2015;6(3):186-190
BACKGROUND: The inclusion of cardiopulmonary resuscitation (CPR) in formal education has been a useful approach to providing basic life support (BLS) services. However, because not all students have been able to learn directly from certified instructors, we studied the educational efficacy of the use of peer-assisted learning (PAL) to train high-school students to perform BLS services. METHODS: This study consisted of 187 high-school students: 68 participants served as a control group and received a 1-hour BLS training from a school nurse, and 119 were included in a PAL group and received a 1-hour CPR training from a PAL leader. Participants' BLS training was preceded by the completion of questionnaires regarding their background. Three months after the training, the participants were asked to respond to questionnaires about their willingness to perform CPR on bystander CPR and their retention of knowledge of BLS. RESULTS: We found no statistically significant difference between the control and PAL groups in their willingness to perform CPR on bystanders (control: 55.2%, PAL: 64.7%,P=0.202). The PAL group was not significantly different from the control group (control: 60.78±39.77, PAL: 61.76±17.80, P=0.848) in retention of knowledge about BLS services. CONCLUSION: In educating high school students about BLS, there was no significant difference between PAL and traditional education in increasing the willingness to provide CPR to bystanders or the ability to retain knowledge about BLS.
7.Postoperative Adjuvant Radiation Therapy in Endometrial Carcinoma.
Kyung Hwan SHIN ; Eun Kyung CHOI ; Seung Do AHN ; Hyesook CHANG ; Jung Eun MOK ; Joo Hyun NAM ; Young Tak KIM ; Yong Man KIM ; Jong Hyeok KIM
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2000;18(1):40-45
PURPOSE: To evaluate the histopathological prognostic factors, relapse pattern and survival in patients with endometrial carcinoma who were treated with surgery and postoperative adjuvant radiotherapy (RT). METHODS AND MATERIALS: From September 1991 to December 1997, 27 patients with endometrial carcinoma treated with surgery and postoperative adjuvant RT at Asan Medical Center were entered in this study. Surgery was performed with total abdominal hysterectomy in six, total abdominal hysterectomy with pelvic lymph node dissection in eight and radical hysterectomy in 13 patients. External RT of 50.4 Gy was done to all patients and among these, additional high dose rate vaginal vault irradiation of 20-25 Gy with fractional dose of 4-5 Gy was boosted in 16 patients. The patients were followed for 6-95 months (median 30). RESULTS: The number of patients according to FIGO stage were I 18 (67%), II 1 (4%) and III 7 (26%). Patients with poor histologic grade, deep myometrial invasion, adnexal involvement, lymphovascular invasion showed more pelvic lymph node involvement, but no statistical significance was indicated. The 5year overall and disease free survival were 100% and 76.8%, respectively. Relapse sites were pelvic, para-aortic lymph node, and multiple metastases including lung, and no vaginal relapse was developed. Factors that were associated with disease free survival were FIGO stage (p=0.01), lymphovascular invasion (p=0.03), pelvic lymph node involvement (p=0.000 1). There was only one Grade 1 rectal bleeding without moderate to severe complications. CONCLUSION: Postoperative adjuvant RT is considered to reduce the loco-regional failure, resulting the improvement of survival. The group of patients with the risk of vaginal failure without vaginal vault irradiation should be investigated according to stage and grade.
Chungcheongnam-do
;
Disease-Free Survival
;
Endometrial Neoplasms*
;
Female
;
Hemorrhage
;
Humans
;
Hysterectomy
;
Lung
;
Lymph Node Excision
;
Lymph Nodes
;
Neoplasm Metastasis
;
Radiotherapy, Adjuvant
;
Recurrence
8.Comparative Clinicopathological Analysis of Primary Neutrophilic Scarring Alopecia:Folliculitis Decalvans and Dissecting Cellulitis
Eun Joo BAEK ; Jin Hyeok HYEONG ; Eun Joo PARK ; Kwang Joong KIM ; Kwang Ho KIM
Korean Journal of Dermatology 2022;60(3):167-172
Background:
Folliculitis decalvans and dissecting cellulitis are types of primary neutrophilic cicatricial alopecia characterized by permanent hair loss. Clinicopathological differentiation is poorly described in literature.
Objective:
This study aimed to determine the clinicopathological distinction between folliculitis decalvans and dissecting cellulitis.
Methods:
A retrospective review was conducted in 45 patients diagnosed with dissecting cellulitis and folliculitis decalvans between 2011 and 2021. We reviewed the clinical features using electronic medical records, clinical photographs, and histopathologic features.
Results:
Clinically, middle-aged men with folliculitis decalvans showed polytrichia (80%) and papulopustules (55%), while young men with dissecting cellulitis had deeply seated nodules (84%). Histopathologically, follicular plugging was more frequently observed in dissecting cellulitis (80%) than in folliculitis decalvans (50%). There was a difference in the depth of inflammation between the two types.
Conclusion
A difference in clinical manifestations was observed according to the depth of inflammation. These findings may contribute to the differential diagnosis of primary neutrophilic cicatricial alopecia.
9.Needs for Hepatitis A Virus Immunization in Healthcare Personnel.
Youn Hee PARK ; Tae Hyong KIM ; Eun Jung LEE ; Tae Youn CHOI ; Hee Bong SHIN ; Eun Ju CHOO ; Min Hyeok JEON ; Hye Kyung JUNG ; Ji Yeon KWON
Korean Journal of Nosocomial Infection Control 2009;14(2):66-71
BACKGROUND: Currently, the incidence of hepatitis A is on the increase in Korea. Although there is emphasis on contact precautions, the nosocomial outbreak of hepatitis A virus (HAV) in healthcare personnel has increased within endemic areas because these workers inevitably come in close contact with patients and work under suboptimal hygiene conditions. In this study, we evaluated the necessity of immunization against HAV for healthcare personnel. METHODS: We investigated the seropositivity of serum immunoglobulin G (IgG) anti-HAV antibody (Ab) in 672 healthcare personnel on the basis of their age-group, sex, and occupation in Soon Chun Hyang University Hospital and Soon Chun Hyang University Bucheon Hospital. RESULTS: The subjects were divided into 6 groups on the basis of their ages to identify differences among the various age groups in the number of cases with HAV Ab seropositivity. Significant intergroup differences were noted in this respect: 21-25 years, 2/152 (1.3%); 26-30 years, 33/245 (13.5%); 31-35 years, 70/148 (47.3%); 36-40 years, 52/79 (65.8%); >40 years, 44/48 (91.7%). CONCLUSION: The number of seropositive cases was low among young healthy personnel: low seropositivity is an emerging risk for vulnerable population. With the increase in the incidence of hepatitis A, healthcare personnel have become a risk population for hepatitis A, as are community residents. Therefore, for healthcare personnel working in hospitals, immunization against HAV should be recommended for personnel younger than 30 years, and serological testing for older personnel.
Delivery of Health Care
;
Hepatitis
;
Hepatitis A
;
Hepatitis A Antibodies
;
Hepatitis A Vaccines
;
Hepatitis A virus
;
Humans
;
Hygiene
;
Immunization
;
Immunoglobulin G
;
Incidence
;
Korea
;
Occupations
;
Serologic Tests
;
Vulnerable Populations
10.Primary Clear Cell Carcinoma of the Ovary ; An Analysis of 9 Cases with Review of the Literature.
Jung Eun MOK ; Ji Yoon JUNG ; Jun Hee NA ; Jong Hyeok KIM ; Bong Hee KIM ; Joor Rung HUH ; Yong Man KIM ; Young Tak KIM ; Joo Hyun NAM
Korean Journal of Obstetrics and Gynecology 1998;41(12):3016-3022
Clear cell carcinoma of the ovary is a clinicopathologic entity with distinct morphologic characteristics and known to be associated with poor prognosis irrespective of stage and prognostic benefits of chemotherapy have not been evidently demonstrated. This represents 2-3.6% of all ovarian malignancies. From October, 1991 to January, 1998, nine patients with primary clear cell carcinoma of the ovary treated in the deptartment of Gynecology and Obstetrics, University of Ulsan, Asan Medical Center were identified, and clinical and histologic review(including architectural pattern, mitotic activity, nuclear grading) was performed retrospectively. The age of the patients ranged from 30 to 67 year(mean+S.D.; 46.0+11.8) and the mean parity was 1.2 (+1.3). Five(55.6%) of nine patients had elevated level of CA 125. The size of the tumors varied from 3 cm to 20 cm with the mean maximal diameter of 12.1 (+6.3) cm. The FIGO stages of the patients were IC(6 cases, 66.7%), IIC (2 cases, 22.2%) and IV(1 case, 11.1%). All patients except one were treated by total abdominal hysterectomy and bilateral salpingoophorectomy with or without omentectomy and pelvic lymph node dissection. All except two were received postoperative chemotherapy with regimens such as CEC (cyclophosphamide + epirubicin + carboplatin), TC(taxol + carboplatin), CC(cyclophosphamide + carboplatin) or CAP (cyclophosphamide + adriamycin + cisplatin). The mean follow-up duration was 14.6 (+ 8.6) months and 8 patients were free of disease and one patient with stage IV disease died of disease during postoperative chemotherapy(4 months after surgery).
Chungcheongnam-do
;
Doxorubicin
;
Drug Therapy
;
Epirubicin
;
Female
;
Follow-Up Studies
;
Gynecology
;
Humans
;
Hysterectomy
;
Lymph Node Excision
;
Obstetrics
;
Ovary*
;
Parity
;
Prognosis
;
Retrospective Studies
;
Ulsan